Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC

Clinical trial NCT05272865 · UNKNOWN

Trial details

NCT number: NCT05272865
Sponsor: LaSanta S A S
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Nausea Post Chemotherapy Vomiting Cancer Pain Cancer Related Pain Neoplasms

Start date: 2023-08-15
Primary completion: 2024-02-15
Enrollment: 334

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.